Cefixime Clinical Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 20, 2021

Primary Completion Date

January 1, 2027

Study Completion Date

June 30, 2027

Conditions
SyphilisHuman Immunodeficiency Virus
Interventions
DRUG

Cefixime 400mg

Oral cefixime 400 mg, one capsule, twice a day for 10 days

DRUG

benzathine penicillin

Standard of care benzathine penicillin G, one intramuscular injection, 2.4MU

Trial Locations (1)

90032

RECRUITING

University of Southern California, Los Angeles

All Listed Sponsors
collaborator

AIDS Healthcare Foundation

OTHER

collaborator

Universidad Peruana Cayetano Heredia

OTHER

lead

University of Southern California

OTHER

NCT04958122 - Cefixime Clinical Trial | Biotech Hunter | Biotech Hunter